Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
BBPvsARKGETF Comparison
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.75% for ARKG. BBP is up 5.62% year-to-date (YTD) with +$4M in YTD flows. ARKG performs worse with -5.11% YTD performance, and -$10M in YTD flows. Run a side-by-side ETF comparison of BBP and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBP vs ARKG performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP ARKG | +2.73%-3.62% | +7.35%-10.23% | +5.62%-5.11% | +41.19%+23.23% | +72.79%-2.84% | +54.18%-70.08% |
| Flows | BBP ARKG | +$4M-$50M | +$16M-$85M | +$4M-$10M | +$19M-$210M | +$19M-$627M | +$9M-$2.79B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP ARKG | +24.64%+39.15% | +25.49%+44.62% | +23.37%+42.26% | +26.10%+45.19% |
| Max drawdown | BBP ARKG | -7.42%-19.50% | -17.97%-23.94% | -25.54%-51.98% | -38.24%-80.33% |
| Max drawdown duration | BBP ARKG | 32d48d | 106d77d | 292d966d | 915d1822d |
BBP | ARKG | |
Last sale 3/13/2026 at 1:30 PM | $81.25 | $26.36 |
| Previous close 03/12/2026 | $81.68 | $26.17 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | ARKG | |
|---|---|---|
| Last price | $81.25 | $26.36 |
| 1D performance | -0.53% | +0.73% |
| AuM | $50.55 M | $1.11 B |
| E/R | 0.79% | 0.75% |
BBP | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Ark Investment |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 58 | 30 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 2, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the BBP and ARKG ETFs performed in 2026?
As of March 11, 2026, BBP is up 5.62% year-to-date (YTD), while ARKG has lost -5.11%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or ARKG?
Year-to-date, the BBP ETF saw +$4M in flows, compared to -$10M for ARKG.
Which ETF is more volatile: BBP or ARKG?
Over the past year, BBP had a volatility of 25.49%, while ARKG experienced 44.62%.
Which ETF is bigger: BBP or ARKG?
As of March 11, 2026, BBP holds $50.55 M in assets under management (AUM), while ARKG manages $1.11 B.
What sectors do the BBP and ARKG ETFs invest in?
BBP leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.
What are the top holdings of the BBP ETF and ARKG ETF?
BBP top holdings include DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS. ARKG holds in its top three: CRISPR THERAPEUTICS, PERSONALIS INC and GUARDANT HEALTH INC.
Which ETF is more diversified: BBP or ARKG?
BBP holds 63 securities with 30.11% of its assets in the top 15. ARKG has 30 securities and a top 15 weight of 63.79%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
